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Abstract 
Purpose/objectives: The complex planning and quality assurance required for spine SBRT are a barrier to imple‑
mentation in time‑sensitive or limited resource clinical situations. We developed and validated an automated inverse 
planning algorithm designed to streamline planning and allow rapid delivery of conformal single fraction spine SBRT 
using widely available technology.
Materials/methods: The Rapid Spine (RaSp) automated script successfully generated single fraction SBRT plans for 
fourteen complex spinal lesions previously treated at a single high‑volume institution. Automated RaSp plans were 
limited to 5 beams with a total of 15 segments (allowing calculation‑based verification) and optimized based on 
RTOG 0631 objectives. Standard single fraction (16 Gy) stereotactic IMRT plans were generated for the same set of 
complex spinal lesions and used for comparison. A conservative 2 mm posterior isocenter shift was used to simulate 
minor set‑up error.
Results: Automated plans were generated in under 5 min from target definition and had a mean dose to the PTV of 
1663 cGy (SD 131.5), a dose to 90 % of PTV (D90) of 1358 cGy (SD 111.0), and a maximum point dose (Dmax) to the 
PTV of 2055 cGy (SD 195.2) on average. IMRT plans took longer to generate but yielded more favorable dose escala‑
tion with a mean dose to the PTV of 1891 cGy (SD 117.6), D90 of 1731 cGy (SD 126.5), and Dmax of 2218 cGy (SD 
195.7). A 2 mm posterior shift resulted in a 20 % (SD 10.5 %) increase in cord dose for IMRT plans and a 10 % (SD 5.3 %) 
increase for RaSp plans. The 2 mm perturbation caused 3 cord dose violations for the IMRT plans and 1 violation for 
corresponding RaSp plans.
Conclusion: The Rapid Spine plan method yields timely and dosimetrically reasonable SBRT plans which meet RTOG 
0631 objectives and are suitable for rapid yet robust pretreatment quality assurance followed by expedited treatment 
delivery. RaSp plans reduce the tradeoff between rapid treatment and optimal dosimetry in urgent cases and limited 
resource situations.
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Background
Spine metastases are a common complication of malig-
nancy, leading to diminished performance status, pain, and 
neurologic compromise. Radiotherapy is the standard for 
non-invasive management of spine metastases in patients 
without mechanical instability or symptomatic spinal cord 
compression. Single fraction conventional treatments such 
as 800 cGy have been shown to be equivalent to fraction-
ated treatment (e.g., 3000  cGy in 10 fractions) in provid-
ing pain relief from metastatic disease of the spine without 
dose limiting or late complications such as myelopathy 
(Hartsell et  al. 2005; Howell et  al. 2013). Nevertheless, as 
many as 60 % of patients treated with conventional spine 
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radiotherapy respond inadequately to treatment and 
retreatment is common. Increasingly conformal radiother-
apy methods employing stereotactic set-up have allowed 
precise and safe delivery of higher doses of radiation to the 
tumor volume with durable local control rates approach-
ing 90 % (Gerszten et al. 2007). A growing body of clinical 
data suggests stereotactic body radiation therapy (SBRT) 
is well tolerated and provides rapid and durable pain relief 
(Ryu et al. 2011; Amdur et al. 2009; Schipani et al. 2012). 
SBRT has the added benefit of shortened overall treatment 
course and smaller treatment volumes with less radiation 
exposure to adjacent normal tissues, potentially maximiz-
ing access to the systemic therapies important in this group 
of patients. Recent prospective trials including an ongoing 
cooperative group study (RTOG 0631) are further inves-
tigating whether clinical outcome measures such as pain 
control are improved with stereotactic radiotherapy com-
pared to conventional radiation therapy.
In general, intensity modulated radiotherapy (IMRT) 
involves inverse planning based on user-defined dosimet-
ric constraints and relies on more complex and dynamic 
segmentation of beams compared to other conformal 
techniques, such as forward planned 3D conformal 
radiotherapy. While other methods utilize multi-leaf col-
limator beam shaping and can employ stereotactic immo-
bilization, IMRT plans are generally thought to produce 
more conformal therapeutic volumes by iterative, com-
putation-intensive inverse planning. There are, however, 
several practical disadvantages to the use of IMRT based 
stereotactic treatments for spine metastases. In resource 
limited situations, the availability of trained dosimetrists, 
planning systems, and linear accelerators equipped 
to perform IMRT based stereotactic therapy are lim-
ited. When available, the complex inverse planning and 
requirement for IMRT patient-specific quality assurance 
(QA) can delay the start of treatment and limit the util-
ity of IMRT in the urgent setting. In the appropriate sce-
nario, calculation-based verification is sufficient and is 
considered both standard and robust (Lo et al. 2013). In 
addition, the steep dose gradients with highly conformal 
treatments require labor-intensive stereotactic treatment 
set-up and verification which can lengthen the treat-
ment time, limit compliance and feasibility in patients 
with severe tumor-related pain, and increase cost and 
resource requirements. With these limitations to IMRT 
in mind, alternative strategies for the rapid and safe deliv-
ery of conformal single fraction radiotherapy are desir-
able. Although planning systems designed to speed the 
process have recently become commercially available, 
such resources are not widely available in the United 
States and worldwide. The present work explores the use 
of an automated inverse planning workflow (Rapid Spine) 
designed to minimize planning time, generate rapid high 
quality plans with limited beam segmentation, and utilize 
non-IMRT calculation-based verification while adher-
ing to RTOG spine SBRT guidelines and dosimetric 
constraints.
Methods
Patient selection and target lesions
Fourteen spinal lesions previously treated at a high vol-
ume institution with either conventional or stereotac-
tic radiation therapy had new single fraction treatment 
plans automatically generated using the Pinnacle Plan-
ning System and automating scripts. The scripts used in 
planning are available from the corresponding author. All 
patients were simulated using a non-contrast enhanced 
CT scan in the supine position with standard immobili-
zation techniques. Twelve lesions abutted the thecal sac, 
eight involved spinal pedicles, seven demonstrated epi-
dural extension, and two were circumferential. It is worth 
noting that controversy exists as to the optimal manage-
ment in cases of epidural extension in light of data sup-
porting downstaging with minimally invasive separation 
surgery prior to SBRT (Laufer et al. 2013). In the present 
study, three patients had undergone debulking surgery, 
one patient underwent pretreatment vertebroplasty, and 
the remainder were not considered candidates for sur-
gical decompression. All patients included had disease 
that was considered clinically urgent. Eight tumors were 
thoracic, five were lumbar, and one was cervical. Details 
including histology, spinal column level, planning target 
volume (PTV) volume, associated symptoms, and lesion 
characteristics are given in Table 1.
Rapid Spine (RaSp) script
An automated inverse planning script was developed 
using the Pinnacle Planning System with the goal of 
yielding a robust algorithm producing systematized 
treatment plans applicable to varied and complex cases 
with minimal need for user individualization. Param-
eters for the script included the delivery of stereotac-
tic doses to the PTV up to the RTOG 0631 standard of 
16 Gy in a single fraction. The spinal cord was contoured 
starting 10 cm above the superior extent of the PTV  to 
10  cm below the inferior extent of the PTV. If neces-
sary, the algorithm limited the prescription dose to meet 
spinal cord constraints as described further below. The 
clinical target volume (CTV) was manually defined by 
the treating physician according to international con-
sortium guidelines (Cox et  al. 2012). For a given plan, 
an automated script automatically placed the isocenter 
at the calculated volumetric centroid point of the tar-
get volume, generated a PTV (2 mm uniform expansion 
of the CTV, excluding the thecal sac), concentric ring 
ROIs for planning, and a truncated thecal sac (limited 
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to the superior/inferior dimensions of the PTV). A sec-
ond sequential script placed either 2, 3, 5, or 7 coplanar 
beams, which were limited to 3 or fewer segments per 
beam. The same script then optimized the treatment plan 
in inverse fashion based on fixed treatment objectives fol-
lowing RTOG 0631 protocol for dose specifications, tar-
get coverage, cord dose limits (Fig. 1). For each patient, 
the final plan was optimized: first, a plan was generated 
using a conservative objective of a point dose maximum 
to the thecal sac of 12 Gy; if this plan did not meet cord 
constraints, then an alternate plan using an objective of 
10 % of the truncated thecal sac receiving less than 10 Gy 
was generated. Both plans were evaluated for adherence 
to treatment objectives. If the objectives on the thecal sac 
were not met by inverse planning, the prescription dose 
was lowered to meet these objectives. A hard constraint 
was placed on cord dose so as not to exceed a point maxi-
mum of 12 Gy with a dose to 10 % of a limited thecal sac 
structure (as defined above) of less than 10 Gy.
In silico simulation of setup error
A 2 mm anterior/posterior shift was manually introduced 
by moving the isocenter posteriorly toward the spinal 
cord to simulate a ‘worst case scenario’ set-up error. A 
2  mm error was chosen to represent the realistic pos-
sibility that set-up errors of this small magnitude may 
routinely occur and go undetected, particularly when 
standard, non-stereotactic immobilization is used—a 
likelihood that is increased in cases where urgent ther-
apy is required. Dosimetric endpoints including CTV 
coverage and cord dose were obtained before and after 
this shift and compared to determine the impact of set-
up error on both IMRT as well as scripted RaSp treat-
ment plans. The intended treatment linear accelerator 
employed a multi-leaf collimator (MLC) leaf size between 
5 and 10 mm.
Results
Fourteen spinal lesions were examined with a mean 
CTV volume of 63.97  cc (range 5.87–182.8). The CTV 
included a single vertebral level for all but one patient, 
where two vertebral levels were included. Histology and 
lesion characteristics varied (Table  1). Single fraction 
IMRT (16 Gy) and 2-, 3-, 5-, and 7-field RaSp automated 
plans were generated for each lesion to cover the target 
volume as described in the “Methods” section. For auto-
mated RaSp plans, increasing beam number resulted in 
more conformal automated plans: the 5-field plans quali-
tatively yielded the best balance between coverage and 
Table 1 Histology and lesion characteristics
ID Diagnosis Level Lesion characteristics Circumferential Symptoms Volume CTV (cc)
1 Spindle cell T8 Epidural extension, compression, T2 Cord changes No Pain, Non focal 29.192
2 Esophageal 
Adeno
L3 Wedge deformity, no canal compromise No Pain, Non focal 41.86
3 Chordoma L2 Pedicle involvement, Mass effect on thecal sac Pedicle Pain, Non focal 82.36
4 Adrenal L3 Circumferential PTV, debulking of L3, vertebrectomy Yes Pain, Non focal 182.8
5 Prostate L5 Retropulsion with canal narrowing, pedicle involvement Pedicle Pain, urostomy 68.14
6 Breast T12 Expansile s/p vertebroplasty, pedicle but no canal Pedicle Pain 46.16
7 Pancreatic T8‑9 Circumferential, T9 compression, epidural extension Yes Pain 129.932
8 Glottic SCC T2 s/p Laminectomy from T2–T4 No Pain, ataxia 5.87
9 Melanoma L5 b/l Pedicles with epidural extension Pedicle Pain, proprioception 37.75
10 Renal cell T8 s/p Resection Pedicle Pain 137.61
11 Colon T12 Extension into central canal with cord displacement Pedicle Pain 63.57
12 Renal cell T8 Posterior pedicle involvement and flattening of cord Pedicle Pain 26.36
13 Renal cell C7 No pedicle, no epidural extension No Pain 16.84
14 Renal cell T3 Pedicle involvement Pedicle Pain 27.06
CT Based Simulation
User generated CTV and OAR 
contours
Automated placement of isocenter, 
scripted generation of PTV, planning 
structures, and a limited cord structure 
based on RTOG definitions.  
Automated generation of 5 
coplanar beams limited to 15 
segments and optimization of 
an inverse treatment plan 
based on RTOG objectives.  
Prescription dose limited 
spinal cord tolerance. 
Caclulation based verification, 
Conventional set-up 
Estimated simulation to 
treatment time: ~2-4 h
Fig. 1 RaSp workflow
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plan simplicity and robustness (Fig. 2). 5-field plans, lim-
ited to 3 segments or fewer per beam, were used for sub-
sequent comparisons with corresponding IMRT plans. 
All automated plans were generated and optimized in 
under 5 min. In comparison, IMRT plans took longer to 
generate, as planning varied from 2 to 4 h. For complex 
lesions, IMRT plans often took more than 4  h to com-
plete multiple iterations during plan optimization. In 
addition, IMRT plans had a higher average beam number, 
and higher total segment count (7.1 [SD 1.0] beams and 
52.6 [SD 11.7] segments).
RaSp plans yielded a mean dose to the PTV of 1663 cGy 
(SD 131.5, 95 % CI 1582.2–1745.1), dose to 90 % of the 
PTV (D90) of 1358  cGy (SD 111.0, 95  % CI 1289.2–
1426.8), and a maximum point dose (Dmax) to the PTV 
of 2055 cGy (SD 195.2, 95 % CI 1934.2–2176.3), on aver-
age. IMRT plans yielded more favorable dose escalation 
with a mean dose to the PTV of 1891  cGy (SD 117.6, 
95 % CI 1818.3–1964.1), D90 of 1731 cGy (SD 126.5, 95 % 
CI 1652.5–1809.5), and Dmax of 2218  cGy (SD 195.7, 
95  % CI 2097.1–2339.7) (Fig.  3). Mean point minimum 
doses were lower but not significantly different between 
RaSp (846.7 cGy, 95 % CI 715.3–978.1) and IMRT plans 
(1035.7 cGy, 95 % CI 875.2–1196.3).
All initial RaSp and IMRT plans met RTOG 0631 spi-
nal cord limits. As stipulated in 0631, the spinal cord dose 
remained below 10 Gy to 10 % of the partial spinal cord 
volume defined as 5–6 mm above and below the target. In 
no case was the dose of 10 Gy exceeded for a spinal cord 
volume of 0.35  cc. The absolute maximum dose to the 
Fig. 2 Representative plan images comparing 2‑, 3‑, 5‑, and 7‑field RaSp plans
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spinal cord remained below 14 Gy for a volume of 0.03 cc. 
Any spinal cord dose that did not meet these criteria 
would have been considered a major deviation in RTOG 
0631 and was therefore considered unacceptable for either 
IMRT or RaSp plans in this study. Treatment plans were 
considered adequate as long as 90  % of the target vol-
ume received the prescribed radiosurgery dose and, as in 
RTOG 0613, dose inhomogeneity within the target volume 
was allowed, provided high dose spillage was limited to 
105 % of the prescription dose outside of the PTV volume.
We compared plan conformality using an R100  % (con-
formality index) as well as intermediate-dose spillage deter-
mined from D2  cm and R50  % parameters. As expected 
IMRT plans demonstrated a trend towards increased con-
formality and steeper dose gradients when compared to 
RaSp plans, with lower R100 % as well as lower D 2 cm, and 
R50  % respectively. These differences, however, were not 
statistically significant, perhaps due to insufficient power 
given the number of lesions in the present analysis as well 
as the wide variation in PTV volumes. R50 % and D 2 cm 
FastPlan IMRT
CE D10% 0.10 0.18

































Fig. 3 Plan comparison. Top panel Representative 5‑field RaSp and IMRT plans with a 2 mm isocenter shift to simulate setup error. Bottom Left Dose‑
volume histogram plots of representative cord and CTV dose for both IMRT and RaSp based plans with and without the 2 mm shift.  Bottom Right 
Bar graph shows the percent change in cord dose (Cord Eval max 10 % and Cord Max to 0.1 cc) following the 2 mm AP shift. Bars represent mean 
percent change for all 14 lesions; error bars show 95 % CI
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parameters in particular are vulnerable to volume variations 
and guidelines typically account for this with target volume 
specific cut offs (e.g., RTOG 0915 lung SBRT guidelines).
A 2  mm posterior shift (high dose volume shifted 
towards the cord), was introduced in silico to simulate 
a small amplitude, worst case set-up error. The 2  mm 
shift resulted in a 20 % (SD 10.5 %) increase in cord dose 
for IMRT plans and a 10 % (SD 5.3 %) increase for RaSp 
plans on average due to the steeper dose gradient with 
IMRT (Fig. 4). The same 2 mm anterior/posterior pertur-
bation caused 3 cord dose violations for the IMRT plans 
and 1 violation for corresponding RaSp plans, illustrating 
a potential vulnerability of increasingly dose escalated 
conformal plans with steep dose fall off.
Discussion
The spine is the most frequent site of skeletal metastatic 
disease, accounting for nearly 20,000 new cases per year 
in the United States (Sciubba et  al. 2009). Radiotherapy 
remains a mainstay of treatment for spine metastases and 
there is mounting evidence for the utility of stereotactic 
radiotherapy in preoperative as well as postoperative set-
tings (Kaloostian et  al. 2014; Chawla et  al. 2009; Sahgal 
et  al. 2011). However, limitations in SBRT as described 
previously have lead us to develop an alternative plan-
ning process. We have explored the feasibility and utility 
of an automated script for the rapid generation of high 
quality conformal spine radiotherapy plans that could be 
planned and delivered with widely available resources. 
Here we report the preclinical validation of the “Rapid 
Spine” algorithm, an easily deployable and robust series 
of Pinnacle scripts which automate the creation of timely, 
dosimetrically reasonable radiotherapy plans designed to 
meet cooperative group standards for spine SBRT. The 
clinical need for such a strategy can be distilled down to 
two basic assumptions: (1) conformal stereotactic treat-
ment is preferable to conventional single fraction radio-
therapy for spine metastases and (2) the ‘standard’ IMRT 
workflow for stereotactic spine treatment impedes timely 
treatment in situations where dose escalation may other-
wise be desirable.
Prospective studies have demonstrated equivalence of 
single fraction radiotherapy relative to fractionated regi-
mens for pain control (Nielsen et  al. 1998; Kaasa et  al. 
2006). Now mounting data from multiple studies have 
demonstrated excellent local control and durable pain 
relief with dose escalation above 8 Gy. Importantly, these 
studies have demonstrated efficacy without compromis-
ing safety, with low rates of complications such as radi-
ation-induced myelopathy. In 2008, Ryu et  al. reported 
on 61 previously unirradiated solitary spine metastasis 
treated at the Henry Ford Hospital to doses between 10 
and 16 Gy, delivered to the vertebral body and paraspinal 
soft tissue (Ryu et al. 2008). In this study, the median dura-
tion of pain relief was 13.6 months. One year overall sur-
vival was 74 % and no cord injury was observed. Similarly, 
at the University of Pittsburgh, Gerszten et al. treated 393 
patients with 500 spinal metastases of varying histology 
and including 344 previously irradiated lesions (Gerszten 
et  al. 2007). The dose range was 12.5–25  Gy and again, 
no cases of radiation-induced myelopathy were reported. 
Long-term pain improvement was noted in 86  % of 
patients at a median follow up of 21 months with a radio-
graphic control rate of 75 % for melanoma, 87 % for renal 
cell carcinoma, and 100 % with breast and lung carcino-
mas. Similar outcomes were reported by Yamada et al. at 
Memorial Sloan-Kettering Cancer Center (103 lesions, 93 
patients, doses 18–24 Gy, no myelopathy) and Gibbs et al. 
at Stanford (102 lesions, 74 patients, 16–26  Gy, 3 cases 
of myelopathy—2 of which were in previously irradiated 
patients) (Yamada et al. 2008; Gibbs 2007).
Despite these and other provocative data intimating 
the potential superiority of stereotactic radiotherapy, few 
generally accepted principles exist as to the criteria for 
routine management of spine metastases with dose esca-
lated radiotherapy (Hall et al. 2011; Thibault et al. 2014). 
The NRG has taken up this questions and the ongoing 
study 0631 seeks to prospectively assess improved clini-
cal outcomes with spine SBRT using single fraction ste-
reotactic treatment (16 Gy). The recently published phase 





















Fig. 4 RaSp vs IMRT. Average dose to 90 % of the PTV (PTV D90), 
mean dose to PTV (PTV Dmean), maximum dose to 10 % of the cord 
(Cord D10 %), and maximum cord dose to 0.1 cc of the cord structure 
(Cord D0.1 cc) are plotted for IMRT and RaSp with and without a 
2 mm AP shift to simulate set‑up error. IMRT plans yielded more 
favorable dose escalation with a higher average PTV dose. A 2 mm 
shift had a greater relative impact on maximum cord dose for IMRT 
plans compared to RaSp plans
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without any grade 4/5 treatment related toxicity for the 
initial 46 patients (Ryu et al. 2014).
In light of emerging data and ongoing studies, stereo-
tactic radiotherapy has gained increasing acceptance as 
a primary modality in the routine management of spine 
metastasis. However, in its present form, IMRT-based 
stereotactic radiotherapy with stereotactic setup imposes 
logistic barriers to timely treatment in urgent and lim-
ited resource settings. Certainly, rigorous standards for 
treatment planning, quality assurance, and institutional 
credentialing are appropriate given the potential risks of 
SBRT (Gerszten et al. 2013). More efficient strategies are 
nevertheless worth exploring, as they may increase access 
to include patients who may benefit from dose escala-
tion in time-sensitive cases or at institutions with limited 
access to resources.
The present work reports on a pilot study validating a 
novel approach aimed at improving efficiency through the 
utilization of automated treatment planning scripts. The 
integrated RaSp workflow consolidates the steps involved in 
stereotactic treatment planning, including CT based simu-
lation, contouring, inverse treatment planning with limited 
beam segmentation, and finally, standard calculation based 
verification (Fig.  1). The RaSp treatment planning algo-
rithm is customizable and relies at its core on a risk adapted 
approach, limiting the final prescription by dose to the spi-
nal cord. The simulation parameters as well as physician 
contouring and delineation of target and OAR structures 
are identical for both RaSp and standard approaches.
Automated RaSp plans were generated quickly (on the 
order of minutes) after target and OAR structures were 
defined and yielded very reasonable dosimetry including 
a mean dose to the PTV of 1663 cGy after limiting dose 
to the spinal cord to RTOG 0631 limits. As expected, 
RaSp plans were less conformal than correspond-
ing IMRT plans as reflected in a trend towards higher 
R100 %. The increased beam number and segmentation 
utilized for IMRT plans (necessitating more labor-inten-
sive IMRT QA for verification) resulted in a steeper dose 
gradient at the PTV/Cord interface, as well as a trend 
towards lower D 2  cm and R50  % intermediate dose 
spillage, allowing more favorable dose escalation with a 
mean dose to the PTV of 1891  cGy—13  % higher than 
corresponding RaSp plans on average. Target coverage 
was similarly improved with IMRT with a 22 % increase 
in PTV D90 over corresponding RaSp plans, on average.
The steeper dose gradient observed with IMRT led us 
to hypothesize that IMRT-based plans may be more sen-
sitive to setup error. Indeed we found that a 2 mm ante-
rior/posterior shift in the isocenter resulted in a 20  % 
(SD 10.5 %) increase in cord dose for IMRT plans and a 
10 % (SD 5.3 %) increase for RaSp plans on average. The 
same 2 mm perturbation caused 3 cord dose violations for 
IMRT plans and only 1 violation for corresponding RaSp 
plans. The smaller dosimetric impact of setup error sug-
gests that appropriate safety may be maintained even dur-
ing urgent therapy of patients in distress. Furthermore, 
in urgent situations where surgery may be preferable to 
SBRT, for example in cases of extensive epidural extension 
of disease (Patchell et al. 2005; Sahgal et al. 2008; Laufer 
et  al. 2013), RaSp may offer an alternative approach for 
safe dose escalation in persons otherwise ineligible for 
surgical decompression. While further investigation is 
required to improve the process proposed here, the pros-
pect of providing a safer and faster option for dose escala-
tion radiation treatment to a broader spectrum of patients 
nationally and worldwide is intriguing.
On the whole, the RaSp algorithm efficiently and robustly 
yielded dosimetrically reasonable plans when compared 
to more resource-intensive IMRT-based spine radiother-
apy. When feasible, more complex planning (e.g. IMRT, 
CyberKnife Multiplan) is preferable given its increased 
conformality and the possibility of increased dose escala-
tion. However, in urgent situations, rapid initiation of treat-
ment is particularly important, especially where invasive 
decompression is contraindicated. Speed of treatment ini-
tiation may be of importance in cases of symptomatic and 
asymptomatic cord compression, and thus may be a value 
to balance against the potential benefit of further dosimet-
ric optimization. Also, in limited resource situations where 
SBRT may be unavailable, patients may benefit from a safe, 
time efficient, and robust method for planning dose esca-
lated single fraction radiotherapy.
Implementations strategies for the clinical utilization of 
RaSp scripting are in development with a focus on opti-
mizing more complex beam geometries yielding more 
favorable conformality, publishing open-source scripts for 
multiple treatment planning platforms, and prospective 
validation in early phase prospective clinical trials. With 
the use of automated scripts, the marginal reduction in 
conformality must be weighed against the benefit of expe-
ditious treatment. Such tradeoffs are appropriately made 
in other clinical circumstances varying from urgent radia-
tion techniques to emergent invasive surgeries, and pro-
spective clinical validation with RaSp is the necessary next 
step in setting a standard for the ideal balance between 
time and conformality. The Rapid Spine approach reduces 
the tradeoff between rapid treatment and optimal dosim-
etry in urgent situations, warranting further development 
and clinical validation of this approach.
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